GEN-PIROXICAM - CAP 20MG CAPSULE
Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
Tabia za bidhaa
(SPC)
12-10-2016
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
PIROXICAM
Inapatikana kutoka:
GENPHARM ULC
ATC kanuni:
M01AC01
INN (Jina la Kimataifa):
PIROXICAM
Kipimo:
20MG
Dawa fomu:
CAPSULE
Tungo:
PIROXICAM 20MG
Njia ya uendeshaji:
ORAL
Vitengo katika mfuko:
100/500
Dawa ya aina:
Prescription
Eneo la matibabu:
OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS
Bidhaa muhtasari:
Active ingredient group (AIG) number: 0114612001; AHFS:
Idhini hali ya:
CANCELLED POST MARKET
Idhini ya tarehe:
2010-08-04
Tabia za bidhaa
_ _
_ _
_Page 1 of 35_
PRODUCT MONOGRAPH
PR
GEN-PIROXICAM
(Piroxicam, USP)
10 and 20 mg Capsules
Nonsteroidal Anti-inflammatory Drug (NSAID)
Genpharm ULC
85 Advance Road
Etobicoke, ON
Canada
M8Z 2S6
DATE OF REVISION:
December 01, 2009
CONTROL NO: 129679
_ _
_ _
_Page 2 of 35_
Table of Contents
PART I: HEALTH PROFESSIONAL
INFORMATION.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL
USE..............................................................................3
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND
PRECAUTIONS..................................................................................5
ADVERSE
REACTIONS..................................................................................................14
DRUG INTERACTIONS
..................................................................................................19
DOSAGE AND
ADMINISTRATION..............................................................................22
OVERDOSAGE
................................................................................................................24
ACTION AND CLINICAL PHARMACOLOGY
............................................................24
STORAGE AND
STABILITY..........................................................................................25
SPECIAL HANDLING INSTRUCTIONS
.......................................................................25
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................25
PART II: SCIENTIFIC INFORMATION
...............................................................................27
PHARMACEUTICAL
INFORMATION..........................................................................27
CLINICAL
TRIALS..........................................................................................................27
DETAIL
Soma hati kamili
